Sepsis-3: How Redefining the World's Deadliest Infection Changed Emergency Medicine — and Sparked a Decade of Debate

Sepsis kills more Americans each year than breast cancer, prostate cancer, and AIDS combined. It is the leading cause of death in U.S. hospitals, responsible for approximately 270,000 deaths annually. It is also one of the most time-sensitive conditions in emergency medicine: every hour of delayed treatment increases mortality by 7%. The question of how to define sepsis — who has it, who does not, and what criteria should trigger aggressive treatment — is therefore not an academic exercise. It is a question with life-and-death consequences for the 1.7 million Americans who develop sepsis each year.

The Old Definition: Sepsis-1 and SIRS (1991–2016)

The first consensus definition of sepsis was published in 1991 by a joint task force of the American College of Chest Physicians and the Society of Critical Care Medicine. The definition introduced the concept of systemic inflammatory response syndrome (SIRS) — a set of four clinical criteria (fever or hypothermia, tachycardia, tachypnea, and abnormal white blood cell count) that, when present in the context of a suspected infection, defined sepsis.

The SIRS-based definition had significant advantages for clinical practice. The four criteria were simple, objective, and measurable at the bedside without laboratory tests. A nurse or physician could quickly assess whether a patient met SIRS criteria and trigger a sepsis protocol. The definition was sensitive — it captured most patients with serious infections — and it was easy to teach and remember.

The SIRS definition also had significant limitations. It was not specific: many patients who met SIRS criteria did not have sepsis — they had other conditions that cause systemic inflammation, including pancreatitis, trauma, burns, and even vigorous exercise. Studies found that up to 47% of ICU patients met SIRS criteria at some point during their admission, and that a significant proportion of these patients did not have infection. The definition was criticized for being too broad — for labeling too many patients as septic and triggering aggressive treatment in patients who did not need it.

The New Definition: Sepsis-3 and qSOFA (2016)

The Sepsis-3 task force, convened in 2014 and publishing its results in JAMA in February 2016, set out to address the limitations of the SIRS-based definition. The task force included 19 critical care and infectious disease specialists from the United States and Europe. It used a data-driven approach, analyzing large clinical databases to identify the clinical variables most strongly associated with mortality in patients with suspected infection.

The Sepsis-3 definition eliminated SIRS criteria entirely. Instead, it defined sepsis as "life-threatening organ dysfunction caused by a dysregulated host response to infection." Organ dysfunction was operationalized using the Sequential Organ Failure Assessment (SOFA) score — a composite measure of dysfunction in six organ systems (respiratory, coagulation, liver, cardiovascular, neurological, and renal). A patient with suspected infection and an acute increase in SOFA score of 2 or more points met the Sepsis-3 definition of sepsis.

For bedside screening — particularly in the emergency department, where SOFA calculation requires laboratory values — the task force introduced the quick SOFA (qSOFA) score: three clinical variables (altered mental status, respiratory rate 22 or more, systolic blood pressure 100 or less). A patient with 2 or more qSOFA criteria was considered at high risk for poor outcomes and warranted further evaluation for sepsis.

The Emergency Medicine Backlash

The emergency medicine community's response to Sepsis-3 was sharply critical. The core objection was that the new definition — designed by intensivists using ICU data — was not validated in the emergency department setting and was not appropriate for use as a screening tool in the ED.

Emergency physicians argued that the SOFA score, which requires laboratory values including creatinine, bilirubin, and platelet count, cannot be calculated at the time of initial patient presentation in the ED — before labs are resulted. The qSOFA score, which was designed to address this limitation, was found in multiple studies to be less sensitive than SIRS criteria for identifying septic patients in the ED. The practical implication was that using Sepsis-3 criteria in the ED would result in delayed recognition of sepsis in a significant proportion of patients.

ACEP issued a statement in 2016 expressing concern about the clinical applicability of Sepsis-3 in the emergency department and recommending that emergency physicians continue to use SIRS-based criteria for sepsis screening until the new definition was validated in ED populations. Several major emergency medicine organizations — including SAEM and AAEM — issued similar statements.

The intensivist community largely defended Sepsis-3, arguing that the old SIRS-based definition was so non-specific that it had lost clinical meaning — that calling a patient with two SIRS criteria "septic" was not useful because it described too many patients with too wide a range of severity. The goal of Sepsis-3, they argued, was to focus clinical attention on the patients who were truly at risk of dying — and the SOFA-based definition did that more accurately than SIRS.

The CMS Sepsis Bundle and the Definition Conflict

The Sepsis-3 controversy was complicated by the existence of the CMS SEP-1 quality measure — a mandatory reporting requirement for hospitals that specified a bundle of interventions (blood cultures, antibiotics, fluid resuscitation, lactate measurement) that must be completed within specified time windows for patients with sepsis. The SEP-1 measure used the old SIRS-based definition of sepsis, creating a situation in which hospitals were being measured by CMS using one definition while the medical literature was moving toward another.

The conflict between the SEP-1 definition and Sepsis-3 created significant confusion at the hospital level. Hospitals that adopted Sepsis-3 criteria for clinical care found that their SEP-1 compliance rates changed — sometimes improving, sometimes worsening — because the two definitions identified different patient populations. Quality improvement teams struggled to reconcile the two frameworks.

CMS updated the SEP-1 measure in 2023 to incorporate elements of Sepsis-3, but the update was partial and the two frameworks remain incompletely aligned. The ongoing tension between the research definition (Sepsis-3) and the regulatory definition (SEP-1) continues to create confusion for clinicians and hospital administrators.

Where Things Stand in 2026

A decade after Sepsis-3, the sepsis definition debate has not been resolved — it has evolved. Most academic medical centers and large hospital systems have adopted Sepsis-3 as their primary definition for research and quality reporting purposes, while continuing to use SIRS-based criteria or hybrid approaches for clinical screening in the emergency department. The qSOFA score has largely fallen out of favor as a standalone screening tool, replaced by NEWS2 (National Early Warning Score 2) and other composite scoring systems that have better sensitivity in ED populations.

The 2026 ACEP/SCCM joint guidelines on sepsis management represent the most recent attempt to reconcile the two frameworks. The guidelines recommend a tiered approach: SIRS criteria or NEWS2 for initial screening in the ED, SOFA for risk stratification once laboratory values are available, and Sepsis-3 criteria for research and quality reporting. The guidelines acknowledge that no single definition is optimal for all clinical contexts and that the choice of screening tool should be guided by the clinical setting and the available resources.

The underlying question — how to identify the patients most likely to benefit from aggressive early treatment without overtreating patients who do not need it — remains unanswered. Sepsis-3 was a genuine advance in the understanding of sepsis pathophysiology. Its clinical implementation, particularly in the emergency department, has been more complicated than its authors anticipated. The debate it sparked has produced a decade of research, improved understanding of sepsis biology, and — ultimately — better care for the patients who need it most.